000			03788nam a2200409 i 4500
999			_c394205 _d394205
001			394205
003			ES-MaUEC
005			20240119142143.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			221018s2022 sz a o |||| 0|eng d
020			_a9783031108396
024	7		_a10.1007/978-3-031-10839-6 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC271.C5 _b2022 EB
100	1		_aCavalcanti, Iago Dillion Lima _eautor _0(orcid)0000-0001-6625-8395 _1https://orcid.org/0000-0001-6625-8395 _4aut _4http://id.loc.gov/vocabulary/relators/aut _9678032
245	1	0	_aChemotherapy Protocols and Infusion Sequence : _bSchedule Consideration in Cancer Treatment _cby Iago Dillion Lima Cavalcanti
250			_a1st edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (X, 325 páginas) _b147 ilustraciones, 145 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
505	0		_aPolypharmacy in cancer therapy -- Combined therapy for the treatment of cancer -- Importance of the infusion order in the treatment of cancer -- Chemotherapeutic protocols for the treatment of breast cancer -- Chemotherapeutic protocols for the treatment of gastrointestinal tract cancer -- Chemotherapeutic protocols for the treatment of genitourinary cancer -- Chemotherapeutic protocols for the treatment of gynecological cancer -- Chemotherapeutic protocols for the treatment of head and neck cancer -- Chemotherapeutic protocols for the treatment of lung cancer -- Chemotherapeutic protocols for the treatment of neurological cancer.
520			_aThis book aims to address the infusion sequence of the main protocols used in the treatment of varied solid cancers. Since an inadequate infusion sequence can compromise the patient's treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence. The introductory chapters present the definition, indication, and the risks and benefits of polypharmacy in cancer therapy, and discuss the importance of drug combination in cancer treatment. Chapter 2 focuses on the challenges and also the toxicity of combination therapy in cancer, while chapter 3 highlights the parameters that must be evaluated before defining the infusion sequence, such as pharmacodynamic and pharmacokinetic profiles, drugs' stability when diluted or reconstituted, toxicological profile of each drug, among others. The remaining chapters are divided by type of cancer. The content is focused on solid tumors, dividing the chapters according to breast, gastrointestinal, genitourinary, gynecological, head and neck, lung, and neurological cancers. In each chapter the epidemiological profiles, pathophysiology, therapeutic modalities, and the main chemotherapy protocols are addressed, as well as efficacy studies and data on the infusion sequence of each mentioned protocol. This work will be a valuable resource to physicians, nurses, and pharmacists, and may help to improve health service practices.
988			_aSpringer_Medicine_2022
650		4	_aCáncer _xQuimioterapia _9674463
776	0	8	_iPrinted edition: _z9783031108389
776	0	8	_iPrinted edition: _z9783031108402
776	0	8	_iPrinted edition: _z9783031108419
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-10839-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b12/2022 _dz _eb _zSI